☆ 4.8 Article

Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma

CANCER RESEARCH (2022)

Get Full Text
Add to Collection

Journal

CANCER RESEARCH
Volume 82, Issue 2, Pages 307-319

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-21-0732

Keywords

-

Categories

Oncology

Funding

  1. NIH [R01 CA194498]
  2. Mayo Clinic Ovarian Cancer SPORE Developmental Award [P50 CA136393]
  3. Mayo Clinic Ovarian Cancer SPORE Career Enhancement Award [P50 CA136393]
  4. Foundation for Women's Cancer Genentech Ovarian Cancer Young Investigator Career Development Award
  5. Wallace and Evelyn Simmers Career Development Award for Ovarian Cancer Research
  6. Minnesota Ovarian Cancer Alliance grant
  7. Ovarian Cancer Research Alliance Liz Tilberis Early Career Award
  8. Novartis Investigator Initiated Studies Program

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.